Skip to main content
. 2019 Aug 20;13(10):2107–2120. doi: 10.1002/1878-0261.12549

Figure 2.

Figure 2

Binding of CD300f antibodies to healthy and leukemic cells. Comparison of CD300f antibodies binding to (A) healthy PBMC populations assessed by multiparameter flow cytometry, (B) AML blasts and CD34+ CD38 subset (n = 5), and (C) Lin CD34+ CD38 CD45RA CD90+ CB hematopoietic stem cells (n = 3). Statistical analysis was performed using t‐tests. *P < 0.05 and **P < 0.01.